Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Thomas Rodi"'
Autor:
Eric Angelini, Gerard Camerini, Malick Diop, Patrice Roche, Thomas Rodi, Christine Schippa, Thierry Thomas
Publikováno v:
PLoS ONE, Vol 11, Iss 2, p e0148769 (2016)
Although the flavor and fragrance industry is about 150 years old, the use of synthetic materials started more than 100 years ago, and the awareness of the respiratory hazard presented by some flavoring substances emerged only recently. In 2001, the
Externí odkaz:
https://doaj.org/article/0a01903c1d0641af840a3d6db9080b75
Autor:
Axel Jame, Charlotte Noizat, Elie Morin, Hélène Paulhac, Yvonnick Guinard, Thomas Rodier, Romain Michenaud, Romain Pigeault, Jean-Louis Yengué, Thibaut Preux, Dominique Royoux, Sophie Beltran-Bech, Nicolas Bech
Publikováno v:
Ecological Indicators, Vol 167, Iss , Pp 112712- (2024)
As a result of human activity, living organisms are faced with the consequences of both climate and landscape changes. These disturbances are particularly significant in urban environments, where an increase of areas are experiencing a rise in temper
Externí odkaz:
https://doaj.org/article/ad32ea3b3c6d4fc5be1ad689565b7e2c
Autor:
Patrice Roche, Eric Angelini, Thomas Rodi, Gerard Camerini, Thierry Thomas, Malick Diop, Christine Schippa
Publikováno v:
PLoS ONE
PLoS ONE, Vol 11, Iss 2, p e0148769 (2016)
PLoS ONE, Vol 11, Iss 2, p e0148769 (2016)
Although the flavor and fragrance industry is about 150 years old, the use of synthetic materials started more than 100 years ago, and the awareness of the respiratory hazard presented by some flavoring substances emerged only recently. In 2001, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a002a73cb2c75382b4abb97563bea762
http://europepmc.org/articles/PMC4749324
http://europepmc.org/articles/PMC4749324
Autor:
Gerard Camerini, Thierry Thomas, Eric Angelini, Thomas Rodi, Maodo Malick Diop, Patrice Roche, Christine Schippa
Publikováno v:
Toxicology Letters. 280:S229
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::541d44a3777da20becece7731e4f43f8
https://doi.org/10.1016/j.toxlet.2017.07.633
https://doi.org/10.1016/j.toxlet.2017.07.633
Autor:
Thomas Rodier, Alicja Puszkiel, Evelina Cardoso, David Balakirouchenane, Céline Narjoz, Jennifer Arrondeau, Vincent Fallet, Nihel Khoudour, Monia Guidi, Michel Vidal, Xavier Declèves, Chantal Csajka, Jérôme Alexandre, Jacques Cadranel, Elizabeth Fabre, Marie Wislez, François Goldwasser, Benoit Blanchet
Publikováno v:
Pharmaceutics, Vol 14, Iss 9, p 1844 (2022)
High interindividual variability (IIV) of the clinical response to epidermal growth factor receptor (EGFR) inhibitors such as osimertinib in non-small-cell lung cancer (NSCLC) might be related to the IIV in plasma exposure. The aim of this study was
Externí odkaz:
https://doaj.org/article/3366d53b548347408d3e034bc944fe1d